Rapid co-release of interleukin 1β and caspase 1 in spinal cord inflammation

Journal of Neurochemistry

Volumn 99, Issue 3, 2006, Pages 868-880

  Clark, Anna K ^a,b   D'Aquisto, Fulvio ^c   Gentry, Clive ^a,b   Marchand, Fabien ^a   McMahon, Stephen B ^a   Malcangio, Marzia ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Caspase; Interleukin; Lipopolysaccharide; Microglia; Neuroinflammation; Release

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL METABOLISM; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ASSAY; ENZYME PHOSPHORYLATION; ENZYME RELEASE; EX VIVO STUDY; GLIA CELL; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; MICROGLIA; MYELITIS; NEUROCHEMISTRY; NEUROPATHOLOGY; NOCICEPTION; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; RAT; SPINAL CORD DORSAL HORN; TISSUE SLICE;

AMINO ACID TRANSPORT SYSTEM ASC; ANIMALS; BEHAVIOR, ANIMAL; CALCITONIN GENE-RELATED PEPTIDE; CASPASE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INFLAMMATION; INJECTIONS, SPINAL; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MICROGLIA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; POSTERIOR HORN CELLS; RATS; SPINAL CORD;

EID: 33750056359     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04126.x     Document Type: Article

References (62)

1. Andersson P. B., Perry V. H. and Gordon S. (1992) The acute inflammatory response to lipopolysaccharide in cns parenchyma differs from that in other body tissues. Neuroscience 48, 169-186.
2. Araque A., Parpura V., Sanzgiri R. P. and Haydon P. G. (1999) Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci. 22, 208-215.
3. Auron P. E., Webb A. C., Rosenwasser L. J., Mucci S. F., Rich A., Wolff S. M. and Dinarello C. A. (1984) Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. Proc. Natl Acad. Sci. USA 81, 7907-7911.
4. Ayala J. M., Yamin T. T., Egger L. A., Chin J., Kostura M. J. and Miller D. K. (1994) IL-1 beta-converting enzyme is present in monocytic cells as an inactive 45-kDa precursor. J. Immunol. 153, 2592-2599.
5. Baldassare J. J., Bi Y. and Bellone C. J. (1999) The role of p38 mitogen-activated protein kinase in IL-1beta transcription. J. Immunol. 162, 5367-5373.
6. Bauer J., Berkenbosch F., Van Dam A. M. and Dijkstra C. D. (1993) Demonstration of interleukin-1 beta in Lewis rat brain during experimental allergic encephalomyelitis by immunocytochemistry at the light and ultrastructural level. J. Neuroimmunol. 48, 13-21.
7. Burns K., Martinon F. and Tschopp J. (2003) New insights into the mechanism of IL-1beta maturation. Curr. Opin. Immunol. 15, 26-30.
8. Cahill C. M., Dray A. and Coderre T. J. (2003) Enhanced thermal antinociceptive potency and anti-allodynic effects of morphine following spinal administration of endotoxin. Brain Res. 960, 209-218.
9. Caivano M. and Cohen P. (2000) Role of mitogen-activated protein kinase cascades in mediating lipopolysaccharide-stimulated induction of cyclooxygenase-2 and IL-1beta in RAW264 macrophages. J. Immunol. 164, 3018-3025.
10. Chauvet N., Palin K., Verrier D., Poole S., Dantzer R. and Lestage J. (2001) Rat microglial cells secrete predominantly the precursor of interleukin-1beta in response to lipopolysaccharide. Eur. J. Neurosci. 14, 609-617.
11. Clark A. K., Gentry C., Bradbury E. J., McMahon S. B. and Malcangio M. (2006) Role of spinal microglia in rat models of peripheral nerve injury and inflammation. Eur. J. Pain in press.
12. Copray J. C. V. M., Mantingh I., Brouwer N., Biber K., Kust B. M., Liem R. S. B., Huitinga I., Tilders F. J. H., van Dam A. M. and Boddeke H. W. G. M. (2001) Expression of interleukin-1 beta in rat dorsal root ganglia. J. Neuroimmunol. 118, 203-211.
13. van Dam A. M., Bauer J., Tilders F. J. H. and Berkenbosch F. (1995) Endotoxin-induced appearance of immunoreactive interleukin-1beta in ramified microglia in rat brain: a light and electron microscopic study. Neuroscience 65, 815-826.
14. DeLeo J. A. and Yezierski R. P. (2001) The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 90, 1-6.
15. Dinarello C. A. (1991) Interleukin-1 and interleukin-1 antagonism. Blood 77, 1627-1652.
16. Dinarello C. A. (1996) Biologic basis for interleukin-1 in disease. Blood 87, 2095-2147.
17. Dinarello C. A. (1997) Interleukin-1. Cytokine Growth Factor Rev. 8, 253-265.
18. Felts P. A., Woolston A. M., Fernando H. B., Asquith S., Gregson N. A., Mizzi O. J. and Smith K. J. (2005) Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide. Brain 128, 1649-1666.
19. Fernihough J., Gentry C., Malcangio M., Fox A., Rediske J., Pellas T., Kidd B., Bevan S. and Winter J. (2004) Pain related behaviour in two models of osteoarthritis in the rat knee. Pain 112, 83-93.
20. Ferrari D., Chiozzi P., Falzoni S., Hanau S. and Di Virgilio F. (1997) Purinergic modulation of interleukin-1beta release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 185, 579-582.
21. Ferreira S. H., Lorenzetti B. B., Bristow A. F. and Poole S. (1988) Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 334, 698-700.
22. Giri J. G., Lomedico P. T. and Mizel S. B. (1985) Studies on the synthesis and secretion of interleukin 1. I. A 33,000 molecular weight precursor for interleukin 1. J. Immunol. 134, 343-349.
23. Hassel B., Paulsen R. E., Johnsen A. and Fonnum F. (1992) Selective inhibition of glial cell metabolism in vivo by fluorocitrate. Brain Res. 576, 120-124.
24. Hou L., Li W. and Wang X. (2003) Mechanism of interleukin-1 beta-induced calcitonin gene-related peptide production from dorsal root ganglion neurons of neonatal rats. J. Neurosci. Res. 73, 188-197.
25. Inoue A., Ikoma K., Morioka N., Kumagai K., Hashimoto T., Hide I. and Nakata Y. (1999) Interleukin-1beta induces substance P release from primary afferent neurons through the cyclooxygenase-2 system. J. Neurochem. 73, 2206-2213.
26. Jin S. X., Zhuang Z. Y., Woolf C. J. and Ji R. R. (2003) p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J. Neurosci. 23, 4017-4022.
27. Joseph E. K. and Levine J. D. (2004) Caspase signalling in neuropathic and inflammatory pain in the rat. Eur. J. Neurosci. 20, 2896-2902.
28. Kim N. G., Lee H., Son E., Kwon O. Y., Park J. Y., Park J. H., Jae Cho G., Sung Choi W. and Suk K. (2003) Hypoxic induction of caspase-11/caspase-1/ interleukin-1beta in brain microglia. Brain Res. Mol. Brain Res. 114, 107-114.
29. Kim S. H., Smith C. J. and Van Eldik L. J. (2004) Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1beta production. Neurobiol. Aging 25, 431-439.
30. Lehnardt S., Lachance C., Patrizi S., Lefebvre S., Follett P. L., Jensen F. E., Rosenberg P. A., Volpe J. J. and Vartanian T. (2002) The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J. Neurosci. 22, 2478-2486.
31. Li P., Allen H., Banerjee S., Franklin S., Herzog L., Johnston C., McDowell J., Paskind M., Rodman L. and Salfeld J. (1995) Mice deficient in IL-1beta-converting enzyme are defective in production of mature IL-1beta and resistant to endotoxic shock. Cell 80, 401-411.
32. MacKenzie A., Wilson H. L., Kiss-Toth E., Dower S. K., North R. A. and Surprenant A. (2001) Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 15, 825-835.
33. Malcangio M. and Bowery N. G. (1996) Calcitonin gene-related peptide content, basal outflow and electrically-evoked release from monoarthritic rat spinal cord in vitro. Pain 66, 351-358.
34. Malcangio M., Bowery N. G., Flower R. J. and Perretti M. (1996) Effect of interleukin-1beta on the release of substance P from rat isolated spinal cord. Eur. J. Pharm. 299, 113-118.
35. Mariathasan S., Newton K., Monack D. M., Vucic D., French D. M., Lee W. P., Roose-Girma M., Erickson S. and Dixit V. M. (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430, 213-218.
36. Martinon F. and Tschopp J. (2004) Inflammatory caspases: Linking an intracellular innate immune system to autoinflammatory diseases. Cell 117, 561-574.
37. Martinon F., Burns K. and Tschopp J. (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 10, 417-426.
38. McMahon S. B., Cafferty W. B. J. and Marchand F. (2005) Immune and glial cell factors as pain mediators and modulators. Exp. Neurol. 192, 444-462.
39. Milligan E. D., O'Connor K. A., Nguyen K. T., Armstrong C. B., Twining C., Gaykema R. P., Holguin A., Martin D., Maier S. F. and Watkins L. R. (2001) Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines. J. Neurosci. 21, 2808-2819.
40. Pearson V. L., Rothwell N. J. and Toulmond S. (1999) Excitotoxic brain damage in the rat induces interleukin-1beta protein in microglia and astrocytes: correlation with the progression of cell death. Glia 25, 311-323.
41. Reeve A. J., Patel S., Fox A., Walker K. and Urban L. (2000) Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. Eur. J. Pain 4, 247-257.
42. Rothwell N. (2003) Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential. Brain Behav. Immun. 17, 152-157.
43. Rubartelli A., Cozzolino F., Talio M. and Sitia R. (1990) A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence. EMBO J. 9, 1503-1510.
44. Rubartelli A., Bajetto A., Allavena G., Cozzolino F. and Sitia R. (1993) Post-translational regulation of interleukin 1beta secretion. Cytokine 5, 117-124.
45. Sanz J. M. and Virgilio F. D. (2000) Kinetics and mechanism of ATP-dependent IL-1beta release from microglial cells. J. Immunol. 164, 4893-4898.
46. Schumann R. R., Belka C., Reuter D., Lamping N., Kirschning C. J., Weber J. R. and Pfeil D. (1998) Lipopolysaccharide activates caspase-1 (interleukin-1-converting enzyme) in cultured monocytic and endothelial cells. Blood 91, 577-584.
47. Singer I. I., Scott S., Chin J., Bayne E. K., Limjuco G., Weidner J., Miller D. K., Chapman K. and Kostura M. J. (1995) The interleukin-1 beta-converting enzyme (ICE) is localized on the external cell surface membranes and in the cytoplasmic ground substance of human monocytes by immuno-electron microscopy. J. Exp. Med. 182, 1447-1459.
48. Svensson C. I., Marsala M., Westerlund A. et al. (2003) Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing. J. Neurochem. 86, 1534-1544.
49. Sweitzer S. M., Colburn R. W., Rutkowski M. and DeLeo J. A. (1999) Acute peripheral inflammation induces moderate glial activation and spinal IL-1beta expression that correlates with pain behavior in the rat. Brain Res. 829, 209-221.
50. Sweitzer S., Martin D. and DeLeo J. A. (2001) Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain. Neuroscience 103, 529-539.
51. Tanga F. Y., Nutile-McMenemy N. and DeLeo J. A. (2005) The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc. Natl Acad. Sci. USA 102, 5856-5861.
52. Thornberry N. A., Bull. H. G., Calaycay J. R. et al. (1992) A novel heterodimeric cysteine protease is required for interleukin-1beta processing in monocytes. Nature 356, 768-774.
53. Tsuda M., Mizokoshi A., Shigemoto-Mogami Y., Koizumi S. and Inoue K. (2004) Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia 45, 89-95.
54. Watkins L. R. and Maier S. F. (2003) Glia: a novel drug discovery target for clinical pain. Nat. Rev. Drug Discov. 2, 973-985.
55. Watkins L. R., Wiertelak E. P., Goehler L. E., Smith K. P., Martin D. and Maier S. F. (1994) Characterization of cytokine-induced hyperalgesia. Brain Res. 654, 15-26.
56. Watkins L. R., Maier S. F. and Goehler L. E. (1995) Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 63, 289-302.
57. Wieseler-Frank J., Maier S. F. and Watkins L. R. (2005) Immune-to-brain communication dynamically modulates pain: Physiological and pathological consequences. Brain Behav. Immun. 19, 104-111.
58. Woodroofe M. N., Sarna G. S., Wadhwa M., Hayes G. M., Loughlin A. J., Tinker A. and Cuzner M. L. (1991) Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production. J. Neuroimmunol. 33, 227-236.
59. Yamamoto M., Yaginuma K., Tsutsui H. et al. (2004) ASC is essential for LPS-induced activation of procaspase-1 independently of TLR-associated signal adaptor molecules. Genes Cells 9, 1055-1067.
60. Yang L. M., Blumbergs P. C. F., Jones N. R. P., Manavis J. B., Sarvestani G. T. P. and Ghabriel M. N. P. (2004) Early expression and cellular localization of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in human traumatic spinal cord injury. Spine 29, 966-971.
61. Yao J. and Johnson R. W. (1997) Induction of interleukin-1 beta-converting enzyme (ICE) in murine microglia by lipopolysaccharide. Brain Res. Mol. Brain Res. 51, 170-178.
62. Zelenka M., Schafers M. and Sommer C. (2005) Intraneural injection of interleukin-1beta and tumor necrosis factor-alpha into rat sciatic nerve at physiological doses induces signs of neuropathic pain. Pain 116, 257-263.